Filing Details

Accession Number:
0001104659-23-114269
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-11-03 16:01:14
Reporting Period:
2023-11-01
Accepted Time:
2023-11-03 16:01:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1420720 Ibio Inc. IBIO Pharmaceutical Preparations (2834) 262797813
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1770235 Martin Brenner C/O Ibio, Inc.
8800 Hsc Parkway
Bryan TX 77807
See Remarks No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-11-01 4,881 $0.27 182,502 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units ("RSUs"). The sales were to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and do not represent a discretionary transaction by the Reporting Person. The RSUs represent a contingent right to receive one share of common stock of iBio, Inc. (the "Issuer").
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.2654 to $0.2671 inclusive. The Reporting Person undertakes to provide to the Issuer, any securities holder of the Issuer, or the staff of the Securities and Exchange Commission, upon report, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.